Skip to main content
. 2022 Jan 19;11(2):191. doi: 10.3390/antiox11020191

Table 4.

Effects of gentamycin induced testicular damage and pioglitazone treatment on body weight, testis weight and relative testis weight.

Group Variable
(Mean ± SEM)
GI (n = 10) GII (n = 10) GIII (n = 10) GIV (n = 10) GV (n = 10)
Body weight (gm) 232.80 ± 8.84 229.50 ± 6.89 241.60 ± 8.47 230.50 ± 5.57 236.40 ± 4.39
Absolute testis weight (mg) 131.50 ± 0.50 b 106 ± 0.53 acde 124.50 ± 2.72 be 133.30 ± 3.47 b 141.9 ± 1.96 bc
Relative testis weight 0.58 ± 0.04 b 0.47 ±0.03 ade 0.52 ± 0.02 0.58 ±0.01 b 0.60 ±0.01 b

GI: CTL, normal control, GII: GM, gentamycin induced testicular damage, GIII: PIO 5 (5 mg/kg/day) pioglitazone treated group, GIV: PIO 10 pioglitazone treated (10 mg/kg/day) and GV: PIO 20 pioglitazone treated (20 mg/kg/day). Values are expressed as mean ± SEM. (a) compared to control group (GI), (b) compared to GM treated group (GII), (c) compared to PIO 5 (GIII) group, (d) compared to PIO 10 (G IV) group, (e) compared to PIO 20 (GV) group.